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T
oday the possibilities for a 
medical journal are almost 
limitless. The ﬁ  rst medical 
journals reﬂ  ected the needs of a 
closed group of doctors. But medicine, 
its place in the world, and the 
dissemination of information have 
changed utterly. So in starting afresh, 
what should a new medical journal 
retain, and what should it ditch? 
Most obviously, we should throw 
out the old way of disseminating 
information. In today’s electronic 
age, it is no more difﬁ  cult, and it is 
only minimally more costly, to provide 
access to one million people than it 
is to one person. So the revolutionary 
idea of anyone being able to read any 
article is possible. This idea—open 
access—which completely challenges 
the old subscription-based publishing 
model, is the driving force behind 
the launch of PLoS Medicine. You 
can download and distribute articles 
without restrictions (feel free to make 
a thousand copies, translate articles 
into other languages, put articles into 
books—just give the author proper 
credit).
We have also changed the way we 
involve the academic community in 
our journal. Our large global editorial 
board reﬂ  ects the diversity of medicine 
today and is intimately involved in what 
we do. In particular, members of the 
editorial board are a crucial part of 
our peer review process. As academic 
editors they, along with a senior editor 
at the journal, take research papers 
through the peer review process in a 
way that we believe provides the most 
constructive and fair review. We are 
delighted that members of our editorial 
board have also shown their support for 
our journal by submitting papers to us, 
even before we launched. 
What will we publish? The research 
article on malaria in this issue reﬂ  ects 
our priority of publishing papers on 
diseases that take the greatest toll 
on health globally. But we will also 
publish papers reporting a substantial 
advance in any specialty, whether that 
advance is in public health, such as the 
paper on the global burden of disease; 
drug effects, such as the paper on the 
effect of HIV drugs on lipids; or the 
molecular understanding of disease, 
such as the paper dissecting out the 
immune responses in lung disease 
caused by smoking. 
A good general medical journal 
should also be a place where the 
global medical community can discuss 
together what matters to them. The 
magazine section of PLoS Medicine will 
be devoted to comment, lively debate, 
and diverse opinions, in particular 
giving neglected voices and diseases a 
place in the limelight. In this issue’s 
magazine section you will see articles 
from ﬁ  ve continents that cover a huge 
range of topics, from basic sciences 
(such as the pathology of emphysema) 
to global public health (such as 
palliative care in developing countries). 
You will ﬁ  nd diverse opinions—for 
example, on whether President Bush is 
helping or hindering Africa’s progress 
towards tackling HIV, and on whether 
health professionals should routinely 
screen women for domestic violence 
(tell us what you think by taking 
our poll at www.plosmedicine.org). 
And you’ll ﬁ  nd case-based learning 
materials on meningitis linked to an 
online video and an online quiz.
Interpretation of results is an 
essential part of a medical journal’s 
job. Although we expect that many 
of our readers will be doctors, we 
hope readers will range from patients 
wanting to learn about the latest 
research on their illness, to teachers 
wanting to use an article in the 
classroom, to policymakers. Hence, 
we have several levels of comment on 
original research. Perspectives, written 
by an expert, are aimed at readers who 
are already familiar with the topic. 
Synopses, written by PLoS Medicine’s 
professional editors, should provide 
any health professional with a quick 
introduction to an article. Patient 
summaries provide a starting point for 
patients to assess the relevance to them 
of a research paper. 
We have decided not to be part 
of the cycle of dependency that has 
formed between journals and the 
pharmaceutical industry, an industry 
that focuses overwhelmingly on the most 
proﬁ  table drugs, thus sidelining many 
of the world’s health problems. Medical 
journals have allowed their interests 
to become aligned with those of the 
pharmaceutical industry by printing 
advertisements for drugs, publishing 
trials designed by drug companies’ 
marketing departments, and making 
proﬁ  ts on reprints used as marketing 
tools. PLoS Medicine will not accept 
advertisements for pharmaceutical 
products or medical devices. Our open-
access license allows free distribution of 
articles, so PLoS cannot beneﬁ  t from 
exclusive reprint sales. And we consider 
as the lowest priority for publication 
papers that are simply aimed at 
increasing a drug’s market share without 
obvious beneﬁ  t to patients. 
We will aim to have the highest 
levels of transparency in our published 
papers. We require authors to tell us of 
any possible competing interests; we in 
turn will tell readers about them. 
But, information ﬂ  ow should not be 
just one-way. Our editorial doors (or 
at least our E-mail boxes) are always 
open. We want your feedback on the 
journal: send us an E-mail or submit an 
eLetter about any article in the journal, 
take part in our polls, contribute 
ideas for the magazine section and 
submit original research. PLoS Medicine 
is a journal for the global medical 
community; we invite you to join in.  
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of anyone being able 
to read any article is 
possible.